DRD DRD
Company Profile ↓Company Overview
DRD (DRD) is a publicly traded company listed on with a market capitalization of $19.77B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 19.3%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 18.9%.
Revenue has grown at a 10.4% CAGR over the past five years.
Trades at an undemanding P/E of 1.5.
Maintains a net profit margin of 21.3%.
Recent Developments
- Jun 2024 Revenue of $6.24B (+13.5% YoY); net profit $1.33B.
- Trailing 12 Months Year-on-year growth — revenue +13.5%, earnings +3.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.4%, profit CAGR 8.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 10.41% |
| 1 Year: | 13.53% |
Compounded Profit Growth
| 5 Years: | 8.73% |
| 1 Year: | 3.69% |
Stock Price Performance
| 1 Year: | +43.96% |
| 6 Months: | -29.40% |
| 3 Months: | -13.44% |
| 1 Month: | +7.27% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)59.04 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 21.3%.
- Compounding revenue at 10.4% over 5 years.
CONS
- Trading 41.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Revenue | 5.12B | 5.50B | 6.24B |
| Cost of Revenue | 3.74B | 3.91B | 4.43B |
| Gross Profit | 1.38B | 1.59B | 1.81B |
| Operating Expenses | 161.20M | 172.90M | 199.30M |
| Operating Income | 1.22B | 1.41B | 1.61B |
| EBITDA | 1.80B | 1.97B | 2.16B |
| Interest Expense | 72.90M | 70.40M | 74.80M |
| Pretax Income | 1.46B | 1.69B | 1.82B |
| Tax Provision | 334.30M | 405.00M | 488.20M |
| Net Income | 1.12B | 1.28B | 1.33B |
| Diluted EPS | 13.06 | 14.82 | 15.35 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Total Assets | 7.08B | 8.15B | 9.45B |
| Current Assets | 3.08B | 3.21B | 1.49B |
| Cash & Equivalents | 2.51B | 2.46B | 509.20M |
| Inventory | 389.30M | 413.60M | 460.00M |
| Receivables | 0 | - | - |
| Total Liabilities | 1.64B | 1.88B | 2.56B |
| Current Liabilities | 625.50M | 718.70M | 953.50M |
| Long Term Debt | - | - | - |
| Total Debt | 52.30M | 39.70M | 29.20M |
| Total Equity | 5.44B | 6.27B | 6.89B |
| Shares Outstanding | 864.59M | 864.59M | 864.59M |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Gross Margin % | 26.9% | 28.8% | 29.0% |
| Operating Margin % | 23.8% | 25.7% | 25.8% |
| Net Margin % | 22.0% | 23.3% | 21.3% |
| ROE % | 20.7% | 20.4% | 19.3% |
| ROCE % | 18.8% | 19.0% | 19.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DRD
3 Gold-Related Stocks to Watch as Gold Outlook Brightens
DRD, IDR and NAK could benefit as State Street sees gold reaching $5,000 by early 2027 and long-term drivers remain supportive after the recent pullback.
Gold's Worst Quarterly Selloff in 13 Years: 3 Miners for the Long Haul
Gold's sharpest quarterly selloff in 13 years may offer a long-haul entry point into DRDGOLD, Newmont and Barrick Mining.
Zacks Industry Outlook Highlights Franco-Nevada, Harmony Gold, Novagold Resources, DRDGOLD and Idaho Strategic Resources
Franco-Nevada, Harmony Gold and other miners are navigating weaker gold prices while advancing growth projects and strengthening operations.
5 Gold Mining Stocks to Buy Despite Industry Headwinds
Recent dip in gold prices and cost pressures weigh on the Zacks Mining - Gold industry. We suggest adding stocks like FNV, HMY, NG, DRD and IDR, which are poised for growth.
3 Affordable Gold Mining Stocks to Buy on the Dip: DRD, IDR, ORLA
While many precious metal stocks had rallied sharply over the past year, a few gold miners still appear attractively valued after recent pullbacks.
Is It Time To Reassess DRDGOLD (NYSE:DRD) After Sharp Share Price Swings?
If you are wondering whether DRDGOLD's share price still reflects its underlying worth, this article walks through what the numbers are saying about value right now. Over shorter periods the stock has been volatile, with a 7.1% gain over th…
DRD — Frequently Asked Questions
What is the current share price of DRD?
As of 2026-08-05 17:25 PDT, DRD trades at $22.87 on NASDAQ/NYSE. Its 52-week range is $14.42 to $38.80.
What is the market capitalisation of DRD?
DRD has a market capitalisation of $19.77B on NASDAQ/NYSE.
What is the P/E ratio of DRD?
DRD trades at a trailing price-to-earnings (P/E) ratio of 1.49. Its price-to-book (P/B) ratio is 2.87.
What is the return on equity (ROE) of DRD?
DRD has a return on equity (ROE) of 19.29%. Its return on capital employed (ROCE) is 18.95%.
Is DRD a good stock to buy?
This page provides a data-driven analysis of DRD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.